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Background: The subject of whether all girls with central precocious puberty (CPP) require brain imaging is
controversial.
Findings: A review of the major papers concerning this topic published since 1994 was conducted looking
primarily at the frequency of occult intracranial lesions, particularly brain tumors, in girls with CPP. While CNS
abnormalities are frequently noted (8–15 %), the proportion of previously unknown findings requiring intervention
in 6–8 year old girls is very small, in the range of 0–2 %.
Conclusion: While MRI should still be done in boys and in girls with onset of puberty younger than age 6 and in
boys, ordering an MRI should not be routine in 6–8 year old girls with CPP. Suggestions are made as to how to
approach the decision-making process with the parents regarding brain imaging in asymptomatic 6–8 year old girls
with CPP.
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Although there is much evidence that female puberty is
starting earlier now than in the past [1, 2], the widely
accepted definition of central precocious puberty (CPP)
remains onset in girls before age 8 and in boys before
age 9. It is considered essential by many pediatric endo-
crinologists to order brain imaging in all children with
CPP to rule out the possibility of a CNS lesion such as a
brain tumor which might require intervention. This
commentary will explore some of the findings which
have been used to support this and why it might be time
to revise this recommendation, at least for girls present-
ing with CPP at greater than 6 years of age.
It has long been known that most cases of girls with
CPP are idiopathic, and estimates during the 1970s and
1980s put this figure at about 80 %. With the widespread
use of CNS imaging beginning in the early 1980s, small
occult CNS lesions could be detected in asymptomatic
girls with CPP, leading to concerns that these lesions, in-
cluding tumors such as astrocytomas and gliomas, might
be missed unless all girls with CPP underwent brain im-
aging. However, in a 1995 report, Bridges et al at
Middlesex Hospital in London [3] reported finding no
small asymptomatic lesions in their series of 91 girls
with CPP, 6 of whom had previously diagnosed intracra-
nial pathology (2 with tumors), and concluded that
obtaining brain imaging on all girls with CPP could not
be justified.
A larger series of patients in a 2000 European study
involving 304 girls with CPP who underwent brain im-
aging found that 18.4 % had a CNS lesion, of which half
were previously known. Of the CNS lesions found, 8.5 %
were newly discovered, though the number involving
neoplasms was smaller [4]. Interestingly, the authors re-
ported no significant age-related differences in the
chances of finding a CNS abnormality, with 7 % of girls
between ages of 7 and 8 having a CNS finding. A 2002
study from France [5] asked the question of whether the
1999 article based on the 1997 PROS study, which pro-
posed a cut-off of 7 years for when puberty should be
considered precocious and require evaluation [6], would
result in missing important CNS lesions. The French
study looked at 197 girls with CPP evaluated from 1982
Correspondence: pkaplowi@childrensnational.org
Division of Endocrinology, Children’s National Health System, Washington,
DC, USA
© 2016 Kaplowitz. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Kaplowitz International Journal of Pediatric Endocrinology  (2016) 2016:9 
DOI 10.1186/s13633-016-0027-5
to 2000 and found 11 (6 %) with a CNS abnormality, but
age of onset was a critical factor; in girls with onset
under age 6, 19 % had a CNS lesion whereas between
the ages of 6 and 8, the incidence was only 2 %. The
authors sought to develop a predictive model which
could identify a group of girls at such low risk that CNS
imaging could be safely avoided. Using this model, they
reported that age <6 years or estradiol >45th %ile identi-
fied all girls with occult intracranial lesions (OCIL).
When the model was applied to a larger group of 443
girls from seven centers in six European countries [7],
the results were similar: 98 % of girls with pubertal onset
after age 6 had idiopathic CPP while 2 % had an OICL,
but for the group with puberty onset before age 6, 29 %
had an OICL. Using an estradiol cutoff of >45th %ile for
girls with CPP according to the distribution of values at
each center identified all 6 girls with onset over age 6
who had an OCIL, but of those who had an estradiol
>45th %ile, only 3 % had an OCIL, still a small propor-
tion. In an editorial accompanying this article, Stanhope
reviewed the existing literature on occult intracranial
tumors in CPP and concluded that “the previous recom-
mendation of denying neuroimaging to girls with CPP
made by Bridges et al can no longer be substantiated. It
is unfortunate to miss the diagnosis of an early and
treatable hypothalamic tumor, such as an astrocytoma,
especially as magnetic resonance imaging does not
involve ionizing radiation” [8].
One problem with the approach of using estradiol as a
key part of decision-making for ordering brain imaging
is that it would still require that imaging be done on
nearly half of girls with CPP. Furthermore, estradiol
levels are notoriously difficult to interpret. Unlike in
males where consistently rising testosterone levels
during puberty allow one to estimate how far along in
the pubertal continuum a boy falls, estradiol levels are
less reliable. Even with the more sensitive assays which
can detect levels as low as 5 pg/mL, it is not unusual to
find girls who are clearly progressing though puberty
with pubertal LH values but estradiol levels which are
not elevated, as well as estradiol levels in the range of
30 pg/mL in girls who during follow-up prove to have
premature thelarche, not CPP. Also given that different
labs use different assays for estradiol, it would fall upon
every center to pool enough results to determine their
45th %ile cut-off to discriminate idiopathic CPP from
CPP due to an OICL, a difficult task.
In 2007, a conference including pediatric endocrinol-
ogists from the North American and European societies
was held to produce a consensus paper on the use of
GnRH analogues in children. One of the topics ad-
dressed was the need for brain imaging in CPP, which
appears to be routine in most European centers but is
not as consistently recommended for 6–8 year old girls
in US centers. The consensus paper [9] acknowledges
this, and stated.
CPP may be a sign of central nervous system pathology.
Unsuspected intracranial pathology has been reported
in 8 % of girls and 40 % of boys without neurologic
findings or neurofibromatosis. The percentage of
children with unsuspected intracranial pathology
decreases with age. Only 2 to 7 % of girls who have
onset of CPP between the ages of 6 and 8 years have
unsuspected pathology, and only ∼ 1 % have a tumor
such as a glioma or astrocytoma. Factors that may
decrease the likelihood of finding a tumor include
racial/ethnic background, family history of CPP, and
adoption.
Conclusions: All boys with CPP and girls with CPP
at <6 years of age should have a head MRI. It is
controversial whether all girls who develop CPP
between 6 and 8 years of age require head MRI.
Girls with neurologic findings and rapid pubertal
progression are more likely to have intracranial
pathology and require an MRI examination (BII).
A 2012 study from Copenhagen reviewed imaging
findings in 229 girls with CPP evaluated during a 16 year
period between 1993 and 2009 who underwent a brain
MRI [10]. Of these, 54 had an abnormal study but 21
were previously known findings, 20 were categorized as
incidental findings including pineal cysts and four pituit-
ary microadenomas, and 13 had new findings on MRI,
which included five arachnoid cysts, two hypothalamic
hamartomas, and only one (0.5 %) newly discovered
tumor requiring surgery, a pilocytic astrocytoma. None-
theless, the authors of this study concluded that “A high
frequency of 6–8 year old girls with precocious
puberty in our study had a pathological brain MRI,
which could not be predicted from any clinical nor
biochemical parameters. Thus, we believe that girls
with precocious pubertal development of central origin
before 8 years of age should continue to be examined
by a brain MRI”.
The most recent study on this topic published in
December 2014 presents findings in 182 girls with breast
development onset before age 8 and a diagnosis of CPP
evaluated at the Bambino Gesu General Hospital in
Rome between January 1990 and December 2012 [11].
All had MRIs with a detailed examination of the
hypothalamic-pituitary area. Normal MRIs were found
in 157 (86 %) while in 14 (8 %) incidental abnormalities
were found, 5 had microadenomas, and only 6 (3 %) had
pathological abnormalities, all hamartomas with no
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tumors requiring surgery. What is important is that all
the girls with hamartomas had onset of puberty before
age 6 (mean age 1.87 years), and had higher baseline and
stimulated LH, FSH and estradiol than girls with idio-
pathic CPP. There was no difference in LH levels be-
tween the five girls with microadenomas and those
without; also the microadenomas that were reimaged did
not increase in size and one disappeared. The authors
also pointed out the importance of a family history of
CPP, as 46 of the girls in their study had a mother or
other relative with menarche at age 10 or younger, and
none had a hamartoma or other important CNS finding.
The authors therefore questioned whether routine MRI
is needed in girls older than age 6 with CPP, particularly
those with a family history, and concluded that better
evidence-based criteria to help with clinical decision
making were needed.
So how should we use the ample data from the studies
cited above to inform the decision as to whether to
order brain imaging in patients with CPP? There is no
argument that all boys with CPP, girls with CPP with
onset before age 6, and any girl with clinical findings
indicating the possibility of a CNS lesion (e.g. severe
frequent headaches, changes in vision or new onset sei-
zures) need brain imaging as the yield of new findings
which may affect clinical management is significant. The
real issue is what to do about girls with CPP onset be-
tween ages 6 and 8 with no CNS-related symptoms, who
form the great majority of CPP patients seen by pediatric
endocrinologists. While rare girls in this category will
harbor an OICL, we should also consider the costs of
doing so many brain MRIs or CTs to find such a small
number (estimated to be in the range of 1 %) of tumors
such as astrocytomas and gliomas which will require
surgery. (It should be acknowledged that there is no
consensus as to how frequent a serious finding must be
to justify expensive imaging studies for many conditions
in medicine). Although brain MRIs do not expose the
child to ionizing radiation, they are significantly more
expensive than CT scans. The average charge in the US
in 2014 was $2600, which does not include the charge
for the neuroradiologist interpreting the study, as well as
sedation which is often needed in children, and IV ad-
ministration of contrast agents, both of which increase
the risk of the procedure. There is also the consideration
that ordering a brain MRI increases parental anxiety and
may be quite stressful for the child. Furthermore, doing
MRIs on girls with CPP at low risk for OICL will result
in picking up minor incidental findings like pituitary
microadenomas, which as pointed out [11], are very un-
likely to be related to CPP. They rarely, if ever, increase
in size during follow-up exams but may result in add-
itional lab testing, a visit to a neurosurgeon and in many
cases at least one more MRI.
Part of the reason the incidence of tumors in 6–8 year
old girls with CPP is so low in recent studies may be
that the incidence of CPP in this age group has in-
creased, as part of a larger trend towards earlier puberty
in girls, the cause of which has been much debated but
is likely due at least in part to the obesity epidemic [12].
The study from Copenhagen of 449 girls evaluated for
early puberty between 1993 and 2007 found a significant
increase after 2003 of both CPP onset before age 8 and
early puberty onset between the ages of 8 and 9 [13]. As
we are seeing more healthy (but often heavy) girls matur-
ing earlier, it is perhaps not surprising that the proportion
with OICL, which was never large, has become very small.
One issue many of us grapple with is the legal implica-
tions of missing a brain tumor in a child with CPP. My
approach to this is to point out to the parents that the
risk of finding a tumor in an asymptomatic 6–8 year old
girl with CPP is at most 1 %, and that I would not rec-
ommend brain imaging given that small risk. I have
found that most parents do not push for imaging when
it is presented that way, but if they cannot live with even
that small amount of uncertainty, then it makes sense to
order the MRI. However, if they are informed of the
small risk and included in the decision-making process,
I believe that the chance of medicolegal challenges in
the unlikely event that a CNS tumor is eventually found
is reduced significantly. We are all well-intentioned pro-
viders wanting to provide the best care for our children
and their families, but in this situation, routine MRIs in
all girls with CPP may not be the optimal approach.
Until we have more reliable guidelines to identify the
rare child with CPP and an OICL, it may be best to review
the available evidence with the parents and get their input
before making a final decision on brain imaging.
Conclusion
Considering the very low frequency of finding brain tumors
which require intervention in 6–8 year old girls with CPP
and no CNS-related symptoms, it is proposed that brain
imaging not be ordered routinely but discussed with
the family after explaining both the benefits and risks
as noted above.
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